TOFRANIL Safety Questions, TOFRANIL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TOFRANIL. Our extensive database of TOFRANIL adverse events and TOFRANIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TOFRANIL
TOFRANIL Safety Reports
Total TOFRANIL reports: 45.TOFRANIL FDA safety alerts: No.
Reported hospitalizations: 24.
Take TOFRANIL Side Effects Survey or Share Your TOFRANIL Story. TOFRANIL Usage.
Pharmacist from JAPAN reported TOFRANIL problem on Dec 21, 2006. Female patient, 81 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. TOFRANIL dosage: 25 MG, BID. Patient recovered.
TOFRANIL problem was reported by a Pharmacist from JAPAN on Dec 25, 2006. Female patient, 81 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. TOFRANIL dosage: 25 MG, BID. Patient recovered.
Consumer or non-health professional from FRANCE reported TOFRANIL problem on Jan 09, 2007. Female patient, 81 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. TOFRANIL dosage: unknown. During the same period patient was treated with ALDACTONE, QUITAXON, ASPIRIN, TEMESTA. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Pharmacist from JAPAN on Jan 11, 2007. Female patient was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. TOFRANIL dosage: 10 MG/DAY. During the same period patient was treated with DOGMATYL. Patient recovered.
Consumer or non-health professional from BRAZIL reported TOFRANIL problem on Jan 26, 2007. Male patient, 13 years of age, weighting 136.7 lb, was diagnosed with convulsion and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: hallucination, insomnia, pyrexia. TOFRANIL dosage: 10 MG, QD. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from FRANCE on Jan 30, 2007. Female patient, 57 years of age, weighting 174.2 lb, was diagnosed with bipolar i disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac failure congestive, cardiomegaly, congestive cardiomyopathy, dyspnoea exertional, ejection fraction decreased, electrocardiogram t wave inversion, hepatojugular reflux, oedema peripheral. TOFRANIL dosage: 20 MG/DAY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on Feb 14, 2007. Male patient, 61 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure increased, body temperature decreased, communication disorder. TOFRANIL dosage: 75 MG/DAY. During the same period patient was treated with TETRAMIDE, TRYPTANOL. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Feb 13, 2007. Male patient, 57 years of age, was diagnosed with pain and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: hallucination, insomnia, labile blood pressure, neuroleptic malignant syndrome, rhabdomyolysis. TOFRANIL dosage: unknown. During the same period patient was treated with MORPHINE, PROCHLORPERAZINE MALEATE, NSAID. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on Feb 21, 2007. Female patient, 23 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood blister, blood cholesterol decreased, coma, erythema, overdose, protein total decreased, rash, skin erosion. TOFRANIL dosage: 25 MG, ONCE/SINGLE. During the same period patient was treated with HALCION. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from BRAZIL on Feb 22, 2007. Female patient, 60 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood bilirubin abnormal, liver disorder. TOFRANIL dosage: 25 MG/D. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on Feb 23, 2007. Male patient, 61 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure increased, body temperature decreased. TOFRANIL dosage: 75 MG/DAY. During the same period patient was treated with TETRAMIDE, TRYPTANOL, DEPAS, CONSTAN, DOGMATYL. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Health Professional from SWITZERLAND on Mar 16, 2007. Male patient, 64 years of age, was diagnosed with bipolar disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, fall, tremor. TOFRANIL dosage: 150 MG/D. During the same period patient was treated with DEPAKENE, LAMICTAL. Patient recovered.
Consumer or non-health professional from BRAZIL reported TOFRANIL problem on Mar 30, 2007. Female patient, 45 years of age, weighting 174.2 lb, was diagnosed with panic disorder, nervousness and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, arrhythmia, constipation, dry mouth, ear operation, euphoric mood, feeling hot, hyperhidrosis. TOFRANIL dosage: 25 MG, 5QD. During the same period patient was treated with LORAX. Patient recovered.
TOFRANIL problem was reported by a Physician from FRANCE on Apr 12, 2007. Female patient, 56 years of age, was diagnosed with bipolar disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: congestive cardiomyopathy, crepitations, ejection fraction decreased, electrocardiogram t wave inversion, heart rate increased, hepatojugular reflux, hypokinesia, oedema peripheral, pulmonary oedema. TOFRANIL dosage: 20 MG, QD. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on May 28, 2007. Male patient, 54 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: liver disorder. TOFRANIL dosage: 25 MG/D. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Mar 29, 2006. Female patient, 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: glossitis, glossodynia, hypoaesthesia oral, oral discomfort, oral pain. TOFRANIL dosage: unknown. During the same period patient was treated with MEILAX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on July 05, 2006. Female patient, 50 years of age, was diagnosed with major depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. TOFRANIL dosage: 150 MG/D. During the same period patient was treated with RISPERIDONE, OLANZAPINE, CHLORPROMAZINE, SULPIRIDE, AMOXAPINE, PAROXETINE, FLUVOXAMINE MALEATE. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from BELGIUM on July 10, 2006. Female patient was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: headache, nervousness, night sweats. TOFRANIL dosage: 25 MG, QID. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on July 05, 2006. Female patient, 50 years of age, was diagnosed with major depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. TOFRANIL dosage: 150 MG/D. During the same period patient was treated with RISPERIDONE, OLANZAPINE, CHLORPROMAZINE, SULPIRIDE, AMOXAPINE, PAROXETINE, FLUVOXAMINE MALEATE. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on July 26, 2006. Male patient, 81 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. TOFRANIL dosage: 20 MG/D. During the same period patient was treated with GASLON, ATARAX. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TOFRANIL problem on July 26, 2006. Male patient, 79 years of age, was diagnosed with benign prostatic hyperplasia and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. TOFRANIL dosage: unknown. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from BRAZIL on July 14, 2006. Female patient, 36 years of age, weighting 125.7 lb, was diagnosed with depression, anxiety and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, delirium, insomnia, sleep disorder. TOFRANIL dosage: 10 MG, TID. During the same period patient was treated with OXCARBAZEPINE, URBANYL, CARBAMAZEPINE. Patient recovered.
Physician from BELGIUM reported TOFRANIL problem on July 10, 2006. Female patient, 65 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: headache, nervousness, night sweats. TOFRANIL dosage: 25 MG, QID. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Mar 29, 2006. Female patient, 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: glossitis, glossodynia, oral pain. TOFRANIL dosage: unknown. During the same period patient was treated with MEILAX. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TOFRANIL problem on July 26, 2006. Male patient, 81 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. TOFRANIL dosage: 20 MG/D. During the same period patient was treated with GASLON, ATARAX. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Mar 29, 2006. Female patient, 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: glossitis, glossodynia, oral pain. TOFRANIL dosage: unknown. During the same period patient was treated with MEILAX. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TOFRANIL problem on July 26, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. TOFRANIL dosage: 10 MG/D. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Aug 31, 2006. Female patient, 73 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: constipation, diverticular perforation, diverticulitis, peritonitis. TOFRANIL dosage: 10 MG/D. Patient recovered.
Physician from JAPAN reported TOFRANIL problem on July 26, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. TOFRANIL dosage: 10 MG/D. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Aug 31, 2006. Female patient, 73 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: constipation, diverticular perforation, diverticulitis, peritonitis. TOFRANIL dosage: 10 MG/D. Patient recovered.
Pharmacist from JAPAN reported TOFRANIL problem on July 27, 2006. Female patient, 83 years of age, weighting 77.16 lb, was diagnosed with back pain, osteoporosis and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, back pain, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure decreased, body temperature decreased, cough. TOFRANIL dosage: 10 MG, QD. During the same period patient was treated with ELCITONIN, BONALON, JUZENTAIHOTO, GLAKAY. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient was diagnosed with enuresis and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: depressed mood, dry skin, erythema, oedema peripheral, skin chapped, somnolence, suicidal ideation. TOFRANIL dosage: 30 MG/DAY. Patient recovered.
Consumer or non-health professional from BRAZIL reported TOFRANIL problem on Oct 03, 2006. Male patient, 27 years of age, weighting 154.3 lb, was diagnosed with incorrect dose administered and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, face oedema, intentional overdose, somnolence, suicide attempt, vomiting. TOFRANIL dosage: 400 MG, ONCE/SINGLE. During the same period patient was treated with DIAZEPAM. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2006. Male patient, 39 years of age, weighting 295.0 lb, was diagnosed with anxiety and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, diabetes mellitus non-insulin-dependent, hepatitis viral, hyperglycaemia, hypertension, weight increased. TOFRANIL dosage: unknown. During the same period patient was treated with PAXIL, EFFEXOR, ZYPREXA. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on June 27, 2007. Female patient, 32 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, glossoptosis, overdose, shock, ventricular tachycardia. TOFRANIL dosage: unknown. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from BRAZIL on July 09, 2007. Female patient, 33 years of age, weighting 141.1 lb, was diagnosed with depression, alcoholism, anxiety and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: cataract, erythema, headache, mass, mydriasis, poisoning. TOFRANIL dosage: 75 MG/D. During the same period patient was treated with DISULFIRAM, RIVOTRIL, NEOZINE, CHLORDIAZEPOXIDE, BIOTONICO. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on July 09, 2007. Female patient, 32 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, electrocardiogram qt prolonged, glossoptosis, overdose, shock, ventricular tachycardia. TOFRANIL dosage: unknown. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from FRANCE on July 10, 2007. Female patient, 17 years of age, weighting 119.0 lb, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blepharospasm, conversion disorder, myoclonus. TOFRANIL dosage: 20 MG, ONCE/SINGLE. During the same period patient was treated with PRIMPERAN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TOFRANIL problem on July 18, 2007. Female patient, 48 years of age, was diagnosed with irritable bowel syndrome and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. TOFRANIL dosage: unknown. During the same period patient was treated with POLYCARBOPHIL CALCIUM, THIATON, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from BRAZIL on Aug 03, 2007. Female patient, 45 years of age, weighting 105.8 lb, was diagnosed with epilepsy, procedural pain and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, dyskinesia, insomnia, somnolence. TOFRANIL dosage: 25 MG, BID. During the same period patient was treated with GARDAN, TENOXICAM, CYCLOBENZAPRINE, RANITIDINE. Patient recovered.
Health Professional from UNITED STATES reported TOFRANIL problem on Aug 09, 2007. Female patient was diagnosed with depression, migraine and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: agitation, depression, dizziness, migraine. TOFRANIL dosage: 10MG 35-45 MG HS PO 20MG 35-45 MG HS PO ON/OFF. Patient recovered.
TOFRANIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2006. Female patient, 47 years of age, weighting 278.0 lb, was diagnosed with sleep disorder and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: delusion, depression, insomnia, poor quality sleep, restlessness, somnolence. TOFRANIL dosage: 25 MG, 3-4 TABLETS AT NIGHT, QD, ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported TOFRANIL problem on Aug 30, 2007. Female patient, 32 years of age, weighting 99.21 lb, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure decreased, cardio-respiratory arrest, depressed level of consciousness, electrocardiogram qt prolonged, glossoptosis, intubation, life support, overdose. TOFRANIL dosage: unknown. During the same period patient was treated with TRIAZOLAM, CLOXAZOLAM, BROMAZEPAM, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.
TOFRANIL problem was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 48 years of age, was diagnosed with irritable bowel syndrome and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, human herpes virus 6 serology positive, liver disorder, pyrexia. TOFRANIL dosage: unknown. During the same period patient was treated with POLYCARBOPHIL CALCIUM, THIATON, LANSOPRAZOLE, SEDIEL, TRANCOLON. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported TOFRANIL problem on Aug 29, 2007. Female patient, 58 years of age, was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hyperglycaemia, loss of consciousness, tachycardia. TOFRANIL dosage: 20 MG/D. During the same period patient was treated with AMOXAN, SEPAZON. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert